Recovery After Severe Abuse and Trauma

Recovery After Severe Abuse and Trauma A critical narrative review of treatment, neurorehabilitation, and functional recovery Written by Jennae Michelle Tropea, RN 21 October 2026

ABSTRACT

This review examines the meaning and evidentiary limits of healing or rewiring the brain after severe abuse. This critical narrative review evaluates treatment evidence relevant to adults with trauma-related symptoms, cognitive complaints, and possible intimate partner violence associated brain injury. An initial purposive corpus assembled on 19 October 2026 was supplemented by a documented, bounded web-index search on 21 October 2026. The synthesis distinguishes symptom improvement, functional recovery, cognitive change, and neural change. Guidelines support trauma-focused psychotherapies for PTSD [3]. One trial in women with childhood abuse-related PTSD reported improvement in both groups [4]. The selected trials measured insomnia-related outcomes, sequenced insomnia/PTSD treatment outcomes, and selected cognitive outcomes in their respective populations. [8, 9, 11] An indexed abstract describes a randomized neuroimaging study reporting treatment-associated functional change [13]. That result does not demonstrate reversal of every type of injury. The cognitive rehabilitation trial discussed here enrolled veterans [11], limiting direct generalization to IPV survivors. The paper proposes an assessment-led care framework that integrates safety, diagnostic clarification, treatment preferences, practical support, and patient-defined functional outcomes. Recovery should be evaluated through meaningful improvements in daily life rather than a presumed return to a universal brain state or an unsupported promise of complete neurological repair.

Keywords: trauma recovery; psychological abuse; PTSD; cognitive processing therapy; EMDR; cognitive rehabilitation; insomnia; intimate partner violence.

INTRODUCTION

The question of how to remedy harm after severe abuse should begin by identifying the harm being treated. This review evaluates PTSD treatment and post-acute brain-injury care as separate evidence domains [3, 10]. The SMART-CPT trial provides an example of combined trauma treatment and cognitive rehabilitation in participants with both PTSD and a TBI history [11]. Improvement in one measured outcome should not be assumed to establish improvement in every other outcome.

This paper examines what the evidence supports about recovery and how those findings can inform a coherent care plan. The present manuscript addresses treatment and outcome interpretation as a self-contained review. Its exposure distinctions and evidence base derive from the studies and guidance cited here, not from a companion paper.

METHOD AND INTERPRETIVE FRAMEWORK

The initial corpus was assembled by purposive retrieval on 19 October 2026, not by a preregistered systematic search. Its original query-level yields were not retained and cannot be reconstructed. To make a bounded update auditable, two additional web-index searches were performed on 21 October 2026 using the exact strings “PTSD childhood abuse randomized phase based immediate EMDR trial results” and “PTSD traumatic brain injury cognitive rehabilitation randomized trial negative outcomes”. The web search service returned a combined batch of 32 displayed records. These are returned records, not database-wide hit counts. Appendix A records every returned item and its selection decision. Earlier exploratory queries and direct citation checks were not counted in that batch.

The update selected completed adult treatment trials addressing sequencing or combined PTSD/cognitive care, prioritizing reports within five years and retaining historical sources for specified contextual and counterevidence purposes. Duplicate repository, publisher, and index records were treated as one study. Protocols, non-treatment exposures, secondary summaries, and other populations or questions were not added to the treatment synthesis. Three recent reports were added: a sequencing analysis, a trial of cognitively augmented behavioral activation, and a comparison of two phase-based treatments. [15-17] Records were screened by this AI-assisted editorial workflow, without independent duplicate screening or a formal risk-of-bias instrument. Primary abstracts support the new trial summaries; no full-text appraisal of those three trials is claimed. The original VA/DoD PTSD guideline and its mTBI provider summary were retrieved directly on 21 October 2026 for the recommendations discussed here. [3, 10]

Selection decisions and a targeted search for negative findings improve traceability but do not establish exhaustive coverage. Web ranking is unstable, English-language accessibility influenced selection, and unselected studies remain a potential source of omitted counterevidence; the two specifically identified cognitive countertrials are now integrated. This is a critical narrative review, not a systematic review or a comprehensive 2026 treatment guideline.

The final revision additionally examined known counterevidence irrespective of whether it favored treatment. Two previously excluded historical cognitive trials were brought into the synthesis because excluding their null or mixed findings while retaining older favorable studies created an asymmetric comparison. [18, 19] Their age limits their currency, not the relevance of their observed comparisons. Contemporary sleep, neural, cognitive, and psychotherapy/medication comparisons were also added. [20-23] The main conclusion is therefore conditional on treatment, comparator, outcome, and population; no overall ranking or pooled benefit is inferred.

A further bounded discovery batch on 21 October used four exact web-index queries: “site.pubmed.ncbi.nlm.nih.gov PTSD psychotherapy medication comparative randomized 2025 primary care written exposure”; “site.pubmed.ncbi.nlm.nih.gov PTSD insomnia prolonged exposure randomized 2025”; “site.pubmed.ncbi.nlm.nih.gov PTSD cognitive rehabilitation SMART 2025”; and “site.pubmed.ncbi.nlm.nih.gov PTSD neural psychotherapy 2023 brain activation”. The returned combined batch contained 38 displayed records, including irrelevant results despite the query prefixes. Its record-level selection ledger is Appendix B. Earlier exploratory queries identified additional candidates and were not counted as this batch. Direct retrieval then examined the selected trial abstracts, publisher texts, and the Fortney correction. The original search cannot be reconstructed retrospectively; this new examination supplements rather than fabricates that history. Selection remains purposive and is not an estimate of all eligible studies.

The review distinguishes four outcomes. Symptom improvement concerns distress and disorder severity. Functional recovery concerns participation in chosen activities. Cognitive improvement concerns abilities such as attention and learning. Neural change concerns measured brain structure or activity. A study can demonstrate one without demonstrating all four. Trials were interpreted according to their actual population, comparator, and measured endpoints. Indexed abstracts were used where full text was inaccessible, limiting detailed appraisal. No pooled treatment effect or formal certainty rating was calculated.

SAFETY AND CLINICAL CLARIFICATION

WHO's clinical handbook places physical care, emotional support, ongoing safety, and continuing support within the same response to violence [1]. This matters because a treatment plan is implemented in a person's actual circumstances. The proposed assessment should ask about continuing threats, privacy, finances, and practical constraints. As a service-design implication, those conditions should be assessed and addressed alongside treatment rather than assumed to disappear when a relationship ends. The individual should retain agency over decisions; the framework is not a mandate for a particular separation plan.

Assessment should distinguish trauma symptoms from a potential history of head injury or strangulation and from other conditions contributing to impairment. A clinician should connect the timeline of symptoms to the exposure history and examination. CDC guidance explains that concussion is not diagnosed solely by a scan [2]. Within this proposed framework, a cognitive complaint should prompt clinical evaluation rather than be treated as a confirmed injury diagnosis [2]. Appropriate evaluation is the bridge between taking the concern seriously and selecting treatment responsibly.

TRAUMA FOCUSED PSYCHOTHERAPY

The VA/DoD 2023 guideline recommends individual trauma-focused psychotherapy, specifically prolonged exposure, cognitive processing therapy (CPT), and eye movement desensitization and reprocessing (EMDR), over medication for PTSD when these approaches are feasible and acceptable [3]. These recommendations concern PTSD outcomes. They should not be translated into claims that a particular therapy restores lost tissue or guarantees complete recovery after every type of abuse.

Treatment selection should consider the person's preferences, clinical presentation, accessibility, and ability to participate. The cited guidance concerns structured psychotherapies [3]. This review provides no instructions for self-directed exposure exercises. The relevant question is which supported approach can be delivered competently and evaluated against agreed goals.

COMPLEX PRESENTATIONS AND TREATMENT SEQUENCING

Bohus and colleagues studied 193 women with childhood abuse-associated PTSD and substantial emotion-regulation difficulties [4]. Both DBT-PTSD and CPT produced improvement [4]. DBT-PTSD had a small between-group advantage on the primary PTSD outcome, with an effect size of 0.33, and lower early dropout [4]. The trial documents improvement in the enrolled population [4]. This review draws no conclusion about attitudes toward treatability. It does not establish DBT-PTSD as superior for all survivors, and the intensive trial format should not be assumed equivalent to every routine service.

Van Vliet and colleagues randomly assigned adults with childhood-abuse-related PTSD to STAIR followed by EMDR (57 participants) or immediate EMDR (64 participants) [5]. They found no statistically significant between-group differences at the post-treatment or follow-up assessments [5]. This trial does not establish that every patient requires or does not require preparatory work; its comparison should be interpreted within the studied population and treatment protocols. Decisions about sequencing should respond to clinical risk, preferences, and actual participation needs rather than an untested assumption that every survivor must complete the same stages.

The proposed interpretation of the Bohus trial is to individualize planning rather than impose a universal sequence [4]. Neither study supplies a blanket answer for ongoing partner violence, severe neurological injury, or every dissociative presentation. Those extensions require separate assessment and evidence.

TREATMENT ACCESS IS PART OF THE OUTCOME

Iverson and colleagues examined IPV exposure in 150 women participating in a CPT study [6]. Their analysis explicitly considered starting treatment, completing treatment, and symptom outcomes [6]. As an interpretive limitation, outcomes observed among participants should not be assigned to people who did not enter the study. Practical barriers should therefore be recorded separately from clinical nonresponse.

For service evaluation, the proposed implication is to report referral, uptake, attendance, completion, and follow-up alongside symptom change. Missed sessions should prompt inquiry rather than automatic interpretation as lack of motivation. These are recommendations for implementation and reporting, not a claim that any one logistical intervention has been shown here to repair the brain.

MEDICATION AS A TARGETED OPTION

The original VA/DoD guideline recommends sertraline, paroxetine, or venlafaxine for PTSD in recommendation 15. It suggests prazosin for PTSD-associated nightmares in recommendation 32 and recommends against benzodiazepines and cannabis for PTSD in recommendations 19 and 20. [3] The National Center for PTSD provides an accompanying clinical summary. [7] Medication decisions require individual assessment of benefits, adverse effects, co-occurring conditions, and preferences. This review does not recommend starting, stopping, or changing any person's medication.

The evidentiary boundary is important: improvement in symptoms with medication is not proof of reversal of a brain lesion. Likewise, a medication being used for another condition does not establish efficacy for PTSD. A research review should identify the target condition and outcome rather than describe every intervention affecting the nervous system as brain healing.

SLEEP AS AN INDEPENDENT TREATMENT TARGET

The trials discussed below evaluate insomnia as a distinct treatment target [8, 9]. In a randomized trial of 45 adults with PTSD and insomnia, Talbot and colleagues evaluated cognitive behavioral therapy for insomnia (CBT-I) against monitoring, supporting a specific role for insomnia treatment [8]. The study was small [8] and does not answer every question about sleep disorders after abuse.

More directly relevant to interpersonal violence, Pigeon and colleagues randomized 110 participants with PTSD, depression, and insomnia to CBT-I followed by CPT or attention control followed by CPT [9]. The CBT-I condition showed greater reductions in insomnia, depression, and PTSD measures at the initial six-week assessment [9]. This supports assessing sleep as a treatment target within a broader plan. [9] It does not establish that sleep treatment alone is adequate for all trauma symptoms or for brain injury. Evaluation should distinguish insomnia from other sleep disorders rather than treating poor sleep as a single diagnosis.

COGNITIVE REHABILITATION WHEN DIFFICULTIES PERSIST

For persistent cognitive symptoms attributed to mTBI, VA/DoD weakly favors a short trial of clinician-directed rehabilitation after other contributors are managed (recommendation 10) and weakly opposes self-administered computer training (recommendation 11). [10]

The provider summary was retrieved directly; its underlying studies were not independently reappraised for this review. These recommendations should not be generalized to every commercial brain-training program or every person with psychological trauma.

Jak and colleagues tested SMART-CPT, integrating compensatory cognitive training with CPT, in 100 veterans with PTSD, a history of mild-to-moderate traumatic brain injury, and cognitive complaints [11]. Both treatment groups improved in PTSD and postconcussive symptoms and quality of life; the integrated approach produced additional improvement in selected cognitive domains [11]. The trial supports considering cognitive needs within trauma treatment. [11] Its veteran population limits direct transfer to civilian IPV survivors, especially those with repeated strangulation or continuing exposure.

In practical terms, rehabilitation should be linked to a defined activity. The proposed goal of a compensatory aid is to support task completion without presuming that the underlying deficit has resolved. Examples of proposed goals include reliably using a reminder system, following a work sequence, or reducing errors in a chosen daily task. Such functional gains are meaningful in their own right. They should not be misrepresented as demonstrated anatomical repair.

PHYSICAL AND NEUROLOGICAL SYMPTOMS

The 2021 provider summary, recommendation 13, suggests symptom-specific care, including a trial of vestibular rehabilitation for persistent dizziness and imbalance in appropriate patients [10]. This illustrates why a single trauma-recovery program cannot be assumed to cover every relevant need. Selection of rehabilitation disciplines and referrals should follow findings rather than a brand or an all-purpose theory of nervous-system regulation.

Recent IPV-specific research reinforces the importance of identifying injury exposure. Makovec Knight and colleagues reported poorer learning and delayed recall in women reporting more than six IPV-related brain injuries compared with the other study groups [12]. This is observational evidence about impairment, not a trial of a remedy. [12] It motivates treatment research and assessment but cannot establish that a particular rehabilitation package works for that population. Dedicated controlled trials are needed.

WHAT NEURAL RECOVERY EVIDENCE SHOWS

The indexed record for Fonzo and colleagues reports that 66 people with PTSD were randomized to immediate prolonged exposure or a waiting-list condition and that functional MRI changes were examined [13]. It reports treatment-associated differences during deliberate reappraisal of negative images, including greater frontopolar activation and connectivity with ventromedial regions, with changes associated with improvement in selected clinical outcomes [13]. These details were not independently verified for this review; the reported functional changes are the neural outcomes discussed here [13].

The interpretation should remain specific. The experiment did not show regrowth of damaged tissue, restoration of every cognitive ability, or reversal of strangulation-associated injury. It also did not establish a scan that routine care must obtain to prove treatment success. In this review’s proposed framework, neural measures are interpreted as mechanistic outcomes, while benefit is evaluated separately through symptom and functional measures.

RECENT FINDINGS AND COUNTERCONDITIONS

Oprel and colleagues examined 96 adults assigned to STAIR followed by prolonged exposure or prolonged exposure alone. Both conditions improved, with no significant between-condition difference in the reported emotion-regulation or later PTSD changes. The proposed mediation through earlier emotion-regulation change was not supported. [15] This finding challenges a universal preparatory-skills mechanism; it does not show that preparatory support is never appropriate.

Wigard and colleagues randomized 68 adults to STAIR followed by either EMDR or narrative therapy. Both groups improved, without significant differences between conditions. [17] Because both arms received STAIR, this comparison cannot isolate STAIR’s added value. [17] Read alongside the immediate-treatment comparison, it shows why improvement within a phased programme and evidence that the phase is necessary are different claims. [5, 17]

Callahan and colleagues randomized 71 veterans with mTBI and PTSD to cognitively augmented behavioral activation or usual treatment. [16] The abstract reports advantages in PTSD symptoms and selected learning and recall measures, with small between-group effects for several outcomes and no significant difference in satisfaction. [16] This adds contemporary evidence for a specific integrated intervention while retaining the small-sample and veteran-population limits. It does not establish benefit from every integrated programme or repair of structural brain injury.

COUNTEREVIDENCE AND OUTCOME-SPECIFIC INTERPRETATION

In 124 adults with mTBI histories and/or PTSD, a trial of nine-hour SMART versus a Brain Health Workshop found improvements in both groups without the hypothesized SMART superiority. [18] This result limits an inference that specialized cognitive training necessarily adds benefit beyond an active educational comparison. It does not establish that either intervention reverses structural injury, and it should not be conflated with the different SMART-CPT protocol.

Elbogen and colleagues randomized 112 veteran-supporter dyads to CALM or Brain Health Training. [19] The trial reported negative executive-dysfunction findings alongside improvements in emotional dysregulation with CALM. [19] This mixed result matters because improvement in anger or interpersonal behavior cannot be substituted for a demonstrated executive-function benefit. Together, these two historical comparisons temper the favorable cognitive findings summarized elsewhere: the measured domain, control condition, and treatment content determine what an improvement means. [11, 18, 19]

More recent evidence also resists a simple superiority narrative. Venza and colleagues studied 148 active-duty service members with mTBI and persistent cognitive complaints, comparing SMART with SCORE. [22] The report describes no between-group difference in overall cognitive gains, while identifying an immediate advantage on one higher-order interpretation measure and fewer SMART treatment hours. [22] This is evidence about a specified comparison and endpoint pattern, not proof that every cognitive programme is interchangeable. An isolated favorable result should not be generalized to every endpoint.

A 94-veteran trial compared CBT-I plus prolonged exposure with sleep hygiene plus prolonged exposure; the CBT-I combination improved insomnia and perceived quality of life more, without a between-group PTSD symptom difference. [20] Thus the rationale for treating sleep can rest on sleep and quality-of-life outcomes without promising an additional PTSD benefit in every setting. This trial qualifies, rather than erases, the favorable findings from differently designed sleep-treatment trials. [8, 9, 20]

Fortney and colleagues' 700-patient primary-care trial found no significant difference in four-month PTSD symptom severity between initial written exposure therapy and SSRI treatment. [23] This contextualizes guideline preferences: a recommendation across evidence and clinical considerations is not a guarantee of superiority in every head-to-head trial. The study concerns brief written exposure in primary care, not a direct comparison of every therapy listed in the guideline. [3, 23] The publisher's correction notice was examined and the corrected article was used in this revision. [24]

Neural interpretation also needs counterweight. Aarts and colleagues synthesized 12 psychotherapy neuroimaging studies involving 191 PTSD patients; their reported activation findings did not survive correction for multiple comparisons. [21] This limits confidence in a reproducible neural signature of recovery. A single mechanistic study can inform a hypothesis, but it cannot establish a universal reversal of abuse-related injury. The meta-analysis is secondary synthesis, not an additional independent treatment trial, and its findings should not be double-counted with its component studies.

Across these comparisons, lack of statistically significant superiority does not prove equivalence, absence of any benefit, or absence of clinically important effects outside the studied sample. The conclusion is narrower: improvement within one arm, superiority over a particular control, change in a cognitive test, and structural repair are distinct propositions. A balanced care framework should retain both favorable and null outcomes and avoid selecting the outcome that best supports a preferred treatment story.

MEASURING MEANINGFUL RECOVERY

The proposed evaluation framework begins with a baseline and a small set of patient-defined goals. The VA describes the PCL-5 as a tool for monitoring PTSD symptom change and identifies a structured clinical interview as the diagnostic gold standard [14]. Sleep, cognitive functioning, participation, and adverse effects should be measured separately when they are treatment targets. Repeated assessments should be interpreted in context, including new exposure, medication changes, and practical disruptions.

For example, a lower symptom score accompanied by continuing inability to retain work instructions is partial improvement, not comprehensive recovery. Better use of compensatory strategies can represent a meaningful functional gain even if a cognitive test changes little. A person may also prioritize being able to rest, sustain a relationship, or participate in a valued activity rather than meeting an externally imposed productivity standard. These examples are proposed applications of outcome-specific evaluation, not numerical findings from a trial.

Recovery should therefore not be defined as visible composure or the capacity to keep working despite substantial symptoms. Nor should lack of rapid progress be treated as proof of permanent damage. Follow-up should ask what improved, what remains impaired, whether the treatment was adequately delivered, and whether the original formulation needs revision.

EVALUATING CLAIMS ABOUT BRAIN HEALING

An intervention claiming to repair trauma-related brain damage should specify the diagnosed condition, study population, comparator, measured endpoint, follow-up period, adverse events, and replication. For this review, symptom improvement, tissue repair, and durable everyday benefit are separate endpoints. Evidence for one endpoint or treatment component is not treated as verification of a different endpoint or an entire proprietary package.

This review does not evaluate every emerging device, supplement, psychedelic intervention, or commercial program. Their omission is not proof of ineffectiveness. It means that the evidence assembled here does not justify recommending them as established remedies for abuse-related brain damage. Claims about any such intervention require their own current appraisal. The same standard applies to a proprietary educational method: a plausible learning rationale is not clinical efficacy evidence.

LIMITATIONS AND RESEARCH PRIORITIES

This narrative review is vulnerable to selective retrieval and does not replace a formal systematic review. Some key trials are older, and access limitations prevented full-text appraisal of every study. The selected trials enrolled different populations, including women with childhood-abuse-associated PTSD, survivors of interpersonal violence, and veterans with PTSD and TBI [4, 9, 11]. This review did not pool these results or estimate a treatment effect specifically for severe adult psychological abuse.

Future studies should characterize coercive control, head injury, and strangulation separately; include survivors with realistic comorbidity and access barriers; and measure both harms and meaningful functional outcomes. Integrated care should be tested rather than presumed superior because it contains more components. Longer follow-up and transparent attrition reporting are essential. Imaging can be useful as a mechanistic measure, but it should not displace outcomes that survivors can recognize in daily life.

CONCLUSION

The comparisons above require treatment claims to be qualified by outcome, comparator, and population. They do not establish a universal repair for all trauma-related brain effects. This review evaluates PTSD guidance [3] and the 2021 post-acute mild TBI provider summary [10] in their respective clinical contexts. The most defensible approach identifies the condition being treated, respects survivor preferences, evaluates practical barriers, and measures change in relevant outcomes. Hope is strongest when it rests on evidence of achievable improvement and preserves honest uncertainty about what remains unproven.

DISCLOSURE

This manuscript was prepared with substantive AI assistance for literature retrieval, synthesis, and drafting. It reports no original participant data and makes no claim of independent peer review. It does not establish clinical efficacy for a proprietary method or replace individualized clinical care.

SOURCE-RECENCY EXCEPTION LEDGER

The five-year window is assessed at 21 October 2026. Older retained sources have limited, source-specific purposes; their inclusion does not substitute for current evidence or waive verification. Reference 1 (2014): historical WHO clinical-response framework for violence; not a current efficacy trial. Reference 4 (2020): direct DBT-PTSD/CPT comparison in a specified childhood-abuse population; not universal comparative superiority. Reference 6 (2011): treatment engagement analysis; not a current prevalence estimate or causal service-intervention trial. Reference 8 (2014): small insomnia-treatment trial, interpreted alongside the later interpersonal-violence trial. Reference 10 (June 2021): dated original agency provider summary for post-acute mTBI; recommendations are reported with their weak strength, not generalized to all trauma. Reference 11 (2019): historical integrated-treatment trial in veterans; contemporary context is supplied by reference 16. Reference 13 (2017): historical mechanistic imaging study; neural change is not tissue regrowth. Reference 18 (2020): historical active-comparator cognitive trial retained to prevent exclusion of relevant null-superiority findings. [18] Reference 19 (2019): historical mixed-outcome rehabilitation trial retained to prevent selective use of older favorable findings. [19] Neither new historical addition is presented as current clinical guidance. Prior source-age approvals are not represented as approval of these new additions.

REFERENCES

1. World Health Organization. Health care for women subjected to intimate partner violence or sexual violence: a clinical handbook. 2014. WHO/RHR/14.26. https://www.who.int/publications/i/item/WHO-RHR-14.26.

2. Centers for Disease Control and Prevention. (2025). About Mild TBI and Concussion. Accessed 19 October 2026. https://www.cdc.gov/traumatic-brain-injury/about/index.html.

3. Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder. Version 4.0. 2023. Provider Summary, recommendations 7, 8, 15, 19, 20, and 32. Retrieved 21 October 2026. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/ptsd/VA-DOD-CPG-PTSD-Provider-Summary.pdf.

4. Bohus M, et al. Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse: A Randomized Clinical Trial. JAMA Psychiatry. 2020;77(12):1235-1245. doi:10.1001/jamapsychiatry.2020.2148. https://pubmed.ncbi.nlm.nih.gov/32697288/.

5. van Vliet NI, et al. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial. BJPsych Open. 2021;7(6):e211. doi:10.1192/bjo.2021.1057. https://www.cambridge.org/core/journals/bjpsych-open/article/phasebased-treatment-versus-immediate-traumafocused-treatment-for-posttraumatic-stress-disorder-due-to-childhood-abuse-randomised-clinical-trial/09A56E1A4C9070A117A05E048C131521.

6. Iverson KM, Resick PA, Suvak MK, Walling S, Taft CT. Intimate partner violence exposure predicts PTSD treatment engagement and outcome in cognitive processing therapy. Behavior Therapy. 2011;42(2):236-248. doi:10.1016/j.beth.2010.06.003. https://pubmed.ncbi.nlm.nih.gov/21496509/.

7. National Center for PTSD. (2025b). Clinician's Guide to Medications for PTSD. Updated 19 November 2025. U.S. Department of Veterans Affairs. Accessed 19 October 2026. https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp.

8. Talbot LS, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014;37(2):327-341. doi:10.5665/sleep.3408. https://pubmed.ncbi.nlm.nih.gov/24497661/.

9. Pigeon WR, Crean HF, Cerulli C, Gallegos AM, Bishop TM, Heffner KL. A Randomized Clinical Trial of Cognitive-Behavioral Therapy for Insomnia to Augment Posttraumatic Stress Disorder Treatment in Survivors of Interpersonal Violence. Psychotherapy and Psychosomatics. 2022;91(1):50-62. doi:10.1159/000517862. https://pubmed.ncbi.nlm.nih.gov/34265777/.

10. Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for the Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury. 2021. Provider Summary, version 3.0, June 2021. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/Rehab/mtbi/VADODmTBICPGProviderSummaryFinal508.pdf. Accessed 21 October 2026.

11. Jak AJ, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. Journal of Neurology, Neurosurgery and Psychiatry. 2019;90(3):333-341. doi:10.1136/jnnp-2018-319315. https://pubmed.ncbi.nlm.nih.gov/30554135/.

12. Makovec Knight J, et al. Brain Injury Within Intimate Partner Violence: What Are the Cognitive Effects? Journal of Neurotrauma. 2026;43(3-4):269-279. doi:10.1177/08977151251388070. https://pubmed.ncbi.nlm.nih.gov/41164911/.

13. Fonzo GA, et al. Selective Effects of Psychotherapy on Frontopolar Cortical Function in PTSD. American Journal of Psychiatry. 2017;174(12):1175-1184. doi:10.1176/appi.ajp.2017.16091073. https://pubmed.ncbi.nlm.nih.gov/28715907/. Indexed abstract retrieved during the final revision; no full-text appraisal claimed.

14. National Center for PTSD. (2026). PTSD Checklist for DSM-5 (PCL-5). Updated 1 October 2026. U.S. Department of Veterans Affairs. Accessed 19 October 2026. https://ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp.

15. Oprel DAC, et al. Phase-based treatment versus immediate prolonged exposure for childhood abuse-related PTSD: The role of emotion regulation improvement in predicting PTSD symptom reduction. Journal of Anxiety Disorders. 2026;121:103174. doi:10.1016/j.janxdis.2026.103174. https://pubmed.ncbi.nlm.nih.gov/42140099/.

16. Callahan ML, et al. Cognitively augmented behavioral activation for veterans with comorbid mild traumatic brain injury and posttraumatic stress disorder. Journal of Traumatic Stress. 2026;39(3):464-477. doi:10.1002/jts.70056. https://pubmed.ncbi.nlm.nih.gov/42046290/.

17. Wigard I, et al. Skills training followed by either EMDR or narrative therapy for posttraumatic stress disorder in adult survivors of childhood abuse: a randomized controlled trial. European Journal of Psychotraumatology. 2024;15(1):2332104. doi:10.1080/20008066.2024.2332104. https://pubmed.ncbi.nlm.nih.gov/38629403/.

18. Samuelson KW, et al. Cognitive Training for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder. Frontiers in Neurology. 2020;11:569005. doi:10.3389/fneur.2020.569005. https://pubmed.ncbi.nlm.nih.gov/33324318/.

19. Elbogen EB, et al. Cognitive Rehabilitation With Mobile Technology and Social Support for Veterans With TBI and PTSD: A Randomized Clinical Trial. Journal of Head Trauma Rehabilitation. 2019;34(1):1-10. doi:10.1097/HTR.0000000000000435. https://pubmed.ncbi.nlm.nih.gov/30169439/.

20. Colvonen PJ, Hunt C, Park J, Angkaw AC, Gehrman P, Clare K, Norman SB. Cognitive Behavioral Therapy for Insomnia With Prolonged Exposure Compared to Sleep Hygiene and Prolonged Exposure: A Randomized Controlled Trial. Journal of Clinical Psychiatry. 2025;86(3):24m15584. doi:10.4088/JCP.24m15584. Indexed abstract: https://pubmed.ncbi.nlm.nih.gov/40488726/ . Publisher byline: https://www.psychiatrist.com/jcp/cbt-insomnia-prolonged-exposure-vs-sleep-hygiene-prolonged-exposure-randomized-controlled-trial/.

21. Aarts I, et al. Effects of psychotherapy on brain activation during negative emotional processing in patients with posttraumatic stress disorder: a systematic review and meta-analysis. Brain Imaging and Behavior. Published online 5 December 2023; print 2024;18(2):444-455. doi:10.1007/s11682-023-00831-0. https://pubmed.ncbi.nlm.nih.gov/38049598/.

22. Venza E, et al. SMART accelerates rate of cognitive gains in service members with mTBI and PTSD. Frontiers in Human Neuroscience. 2025;19:1542422. doi:10.3389/fnhum.2025.1542422. https://pubmed.ncbi.nlm.nih.gov/40416902/.

23. Fortney JC, et al. Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025;82(12):1203-1215. doi:10.1001/jamapsychiatry.2025.2962. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2840223.

24. Error in Abstract. JAMA Psychiatry. 2025;82(12):1256. doi:10.1001/jamapsychiatry.2025.3719. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2842274.

APPENDIX A: BOUNDED UPDATE SELECTION LOG

Date: 21 October 2026. Platform: web search service, system2_search_query. Exact query strings and limitations are reported in Methods. The following 32 records comprise the returned combined batch, screened by title/abstract or returned description. “Not added” is a selection decision, not a negative efficacy finding. The underlying corpus retains WHO safety guidance [1], CDC diagnostic information [2], agency PTSD guidance [3, 7], comparative therapy trials [4, 5], engagement analysis [6], sleep trials [8, 9], mTBI guidance [10], integrated treatment [11], observational IPV context [12], mechanistic imaging [13], and outcome measurement guidance [14]. Each serves that specific purpose; observational and mechanistic studies are not counted as remedy trials.

Record 1. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial Decision: Retained existing trial, reference 5.

Record 2. Cognitive Rehabilitation With Mobile Technology and Social Support for Veterans With TBI and PTSD: A Randomized Clinical Trial - PubMed Decision updated in final revision: integrated as historical counterevidence, reference 19; initial exclusion by age reversed to avoid asymmetric selection.

Record 3. Cognitive Rehabilitation for Traumatic Brain Injury: A Randomized Trial | Traumatic Brain Injury | JAMA | JAMA Network Decision: Not added: older moderate-to-severe TBI inpatient trial outside update population/window.

Record 4. Cognitive Rehabilitation with Mobile Technology and Social Support for Veterans with TBI and PTSD: A Randomized Clinical Trial - PMC Decision: Duplicate of record 2.

Record 5. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial | BJPsych Open | Cambridge Core Decision: Duplicate of record 1.

Record 6. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: Randomised clinical trial (BJPsych Open) - EMDR International Association Decision: Secondary description of record 1.

Record 7. Phase-based treatment versus immediate prolonged exposure for childhood abuse-related PTSD: The role of emotion regulation improvement in predicting PTSD symptom reduction - PubMed Decision: Added after abstract verification, reference 15.

Record 8. Phase-based treatment versus immediate prolonged exposure for childhood abuse–related PTSD: The role of emotion regulation improvement in predicting PTSD symptom reduction - ScienceDirect Decision: Duplicate of record 7.

Record 9. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial | Journal of Neurology, Neurosurgery & Psychiatry Decision: Retained historical exception, reference 11.

Record 10. Cognitively augmented behavioral activation for veterans with comorbid mild traumatic brain injury and posttraumatic stress disorder. Decision: Added after abstract verification, reference 16.

Record 11. Cognitive Training for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder. Decision updated in final revision: integrated as historical counterevidence, reference 18; initial exclusion by age reversed to avoid asymmetric selection.

Record 12. Phase-based treatment versus immediate prolonged exposure for childhood abuse–related PTSD: The role of emotion regulation improvement in predicting PTSD symptom reduction - ScienceDirect Decision: Duplicate of record 7.

Record 13. Cognitive Training for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder Decision: Duplicate of record 11.

Record 14. Predicting optimal treatment outcomes in phase-based treatment and direct trauma-focused treatment among patients with posttraumatic stress disorder stemming from childhood abuse. Decision: Not added: predictor analysis rather than new comparative treatment trial.

Record 15. Cognitive Rehabilitation for Military Service Members With Mild Traumatic Brain Injury: A Randomized Clinical Trial - PubMed Decision: Not added: older military rehabilitation trial outside update window.

Record 16. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Decision: Not added: older childhood-abuse treatment trial outside update window; historical sequencing evidence may be omitted.

Record 17. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: Randomised clinical trial - Tilburg University Research Portal Decision: Duplicate of record 1.

Record 18. Skills training followed by either EMDR or narrative therapy for posttraumatic stress disorder in adult survivors of childhood abuse: a randomized controlled trial - PubMed Decision: Added after abstract verification, reference 17.

Record 19. Worse baseline executive functioning is associated with dropout and poorer response to trauma-focused treatment for veterans with PTSD and comorbid traumatic brain injury. Decision: Not added: older predictor analysis rather than new comparative trial.

Record 20. Cognitive rehabilitation for adults with traumatic brain injury to improve occupational outcomes - PMC Decision: Not added: older secondary review, not primary treatment trial.

Record 21. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. Decision: Duplicate of record 9.

Record 22. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: Randomised clinical trial - Vrije Universiteit Amsterdam Decision: Duplicate of record 1.

Record 23. UCSD Brain Injury Trial → Improving Cognitive Rehabilitation Outcomes Decision: Not added: ongoing trial record, no completed outcome evidence in returned record.

Record 24. WRaP - Worcester Research and Publications Decision: Duplicate of record 1.

Record 25 (PDF search-result locator normalized to article DOI). Cognitive Training for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder Decision: Duplicate of record 11.

Record 26. The Study of Cognitive Rehabilitation Effectiveness Decision: Not added: older SCORE report outside update window.

Record 27 (returned search label: BMC Psychiatry; PDF locator normalized to article DOI). Treatment of multiple traumatized adolescents by enhancing regulation skills and reducing trauma related symptoms: rationale, study design, and methods of randomized controlled trial (the Mars-study) Decision: Not added: protocol, no completed treatment outcomes.

Record 28. Exploring the Efficacy of a Residential Treatment Program Incorporating Cognitive Processing Therapy-Cognitive for Veterans With PTSD and Traumatic Brain Injury Decision: Not added: older residential study outside update window.

Record 29. Traumatic Brain Injury Center of Excellence Decision: Not added: secondary research review; direct trials prioritized.

Record 30. 11-22-10-Clinical Trial on Cognitive Rehabilitative Therapy Decision: Not added: older overview/report outside update window.

Record 31. Effects of Repetitive Low-Level Blast Exposure on Mental Health in Veterans Decision: Not added: blast exposure study, not treatment trial.

Record 32. SMART-TBI: Design and Evaluation of the Social Media Accessibility and Rehabilitation Toolkit for Users with Traumatic Brain Injury Decision: Not added: social-media accessibility toolkit, outside the clinical-treatment question.

APPENDIX B: ADDITIONAL DISCOVERY AND SELECTION

The 38 records below preserve the returned search labels, including truncated labels. The complete returned URLs and search output are retained in the editorial search record. Discovery locators for excluded records are not additional scientific references. Exact queries, date, and scope are in Methods. Selection was purposive and does not establish exhaustive coverage.

B1. Pragmatic Comparative Effectiveness of Primary Care Treatments ... Decision: Added as reference 23; corrected publisher article and correction notice examined.

B2. Exploration of a Novel Model of Intrusive Symptoms ... - PubMed Decision: Not added: symptom-model study, not a treatment comparison.

B3. Posttraumatic Stress Disorder - StatPearls - NCBI Bookshelf Decision: Not added: general secondary textbook; original agency guidance retained.

B4. Effects of psychotherapy on brain activation during ... Decision: Added as reference 21 to test strength of neural-change interpretation.

B5. A Review of PTSD and Current Treatment Strategies - PMC Decision: Not added: general secondary overview; direct guidance and comparisons used.

B6. Sleep Education for Insomnia in PTSD Decision: Not added: recruitment listing, not completed outcome evidence.

B7. SMART-CPT for veterans with comorbid post-traumatic stress ... Decision: Already retained, reference 11.

B8. Trauma Timing and Its Impact on Brain Activation During ... Decision: Not added: trauma-timing/neural study rather than the selected treatment-outcome comparison.

B9. Patient perspectives on the effectiveness of written exposure therapy ... Decision: Not added: patient-perspective analysis; randomized outcome article retained as reference 23.

B10. Accelerated Treatment for Co-occurring Insomnia, ... Decision: Not added: registered trial without completed outcomes in returned record.

B11. Cognitive Rehabilitation with Mobile Technology and Social ... Decision: Integrated via primary indexed record as reference 19.

B12. Augmenting evidence-based PTSD psychotherapy with ... - PMC Decision: Not added: emerging-intervention overview outside the selected established-care domains.

B13. Prolonged Exposure for PTSD - PTSD: National Center for PTSD Decision: Context checked; original guideline supplies recommendations in reference 3.

B14. Post-traumatic stress disorder - NCBI Bookshelf - NIH Decision: Not added as an additional guideline; original VA/DoD documents define this review's guidance frame.

B15. Evolving Psychotherapeutic Approaches for PTSD - PMC - NIH Decision: Not added: broad psychotherapy review, not a new head-to-head comparison.

B16. Written Exposure Therapy as Transformative, Scalable Care for ... Decision: Not added: news/perspectives article, not trial evidence.

B17. Cognitive-Behavioral Therapy for PTSD, Insomnia, and ... Decision: Not added: recruitment listing rather than completed outcomes.

B18. Trauma-Informed Therapy - StatPearls - NCBI Bookshelf Decision: Not added: general secondary account of trauma-informed therapy.

B19. Post-traumatic stress disorder: the role of the amygdala and ... Decision: Not added: broad neurobiology review rather than treatment-change synthesis.

B20. Post-traumatic stress disorder treatable in primary care - UW Medicine Decision: Duplicate news coverage of reference 23; primary article used.

B21. Sleep As Mediator in the Pathway From Violence-Induced ... Decision: Not added: older mediator review; selected direct sleep trials used.

B22. Evaluation of post-traumatic stress disorder (PTSD) and ... Decision: Not added: broad PTSD/TBI evaluation rather than the selected rehabilitation comparison.

B23. List of Excluded Studies - NCBI - NIH Decision: Not added: another review's exclusion list, not independent trial evidence.

B24. Search Decision: Not added: grant record rather than completed outcome report.

B25. Neural Correlates of Cognitive Rehabilitation in Post- ... Decision: Not added: trial registration; not used as completed efficacy evidence.

B26. Activation Likelihood Estimation Meta-Analysis of the Effects of ... Decision: Not added: multi-disorder CBT synthesis; PTSD-specific synthesis selected.

B27. Primary care treatment of PTSD with SSRIs or written exposure ... Decision: Duplicate social-media description of reference 23.

B28. Project Details Decision: Not added: grant record rather than completed outcome report.

B29. A meta-analytic review of cognitive processing therapy for ... Decision: Not added: older general CPT synthesis; no pooled CPT estimate attempted here.

B30. Neurofeedback for post-traumatic stress disorder - PMC - NIH Decision: Not added: neurofeedback outside this review's selected established-care scope.

B31. VA Research Identifies Effective Strategies for Primary Care Teams ... Decision: Duplicate secondary reporting of reference 23.

B32. The Impact of Prolonged Exposure on Sleep and ... Decision: Not added: older sleep pilot; direct 2025 active-comparator sleep trial selected. Possible omitted detail acknowledged.

B33. National Center for Biotechnology Information Decision: Not a study record; search landing page.

B34. Changes in neural responses during affective and non ... - PMC Decision: Candidate neural primary study; publisher retrieval failed. Not synthesized; PTSD-specific meta-analysis selected, without treating it as independent of component trials.

B35. Real-time fMRI neurofeedback training of the amygdala activity with simultaneous EEG in veterans with combat-related PTSD Decision: Not added: neurofeedback preprint outside selected scope.

B36. Thousand Voices of Trauma: A Large-Scale Synthetic Dataset for Modeling Prolonged Exposure Therapy Conversations Decision: Not added: synthetic dialogue dataset, not human treatment outcomes.

B37. SMART-TBI: Design and Evaluation of the Social Media Accessibility and Rehabilitation Toolkit for Users with Traumatic Brain Injury Decision: Not added: social-media accessibility toolkit outside clinical treatment comparison.

B38. How Real Are Synthetic Therapy Conversations? Evaluating Fidelity in Prolonged Exposure Dialogues Decision: Not added: synthetic dialogue evaluation, not human treatment outcomes.

APPENDIX C: LINK AND SOURCE-ACCESS RECORD

On 21 October 2026, each of the 44 distinct URLs in the preceding manuscript version was submitted to the web retrieval service. This was a complete attempted sweep of those locators, not a claim that every website returned its full text. Returned pages, access restrictions, and extraction failures were retained in the editorial record. Redundant hyperlinks to excluded or duplicate search records were removed from the printed selection ledgers while preserving their labels, decisions, and full raw discovery record. Source references remain linked.

Bibliography access: references 1, 2, 7, and 14 returned official agency pages; references 3 and 10 returned original agency PDFs. References 8, 9, 13, 15, 16, 19, 20, and 21 returned substantive PubMed records. Reference 5's repository link encountered a browser-verification page and was replaced with the successfully retrieved original Cambridge article. References 18 and 22 returned full publisher articles; reference 23 returned the corrected publisher article and reference 24 its correction notice. References 4, 6, 11, 12, and 17 returned only a minimal page through the web extractor in this sweep; their source identities and substantive indexed records were nevertheless retrieved by the manuscript evidence audit. These access limits are disclosed rather than reported as broken links or successful full-text appraisal. No universal uptime guarantee is claimed.

The source-status check identified an actual correction for reference 23; it is recorded in reference 24 and incorporated into the discussion. Record-level status checks cannot guarantee absence of every subsequent notice. For references 18 and 19, the final evidence audit must assess source support and status separately from the age-retention rationale.

Reference metadata note: Reference 21 distinguishes its 2023 online publication from the 2024 print issue. Publisher full texts for references 18 and 22 were examined; the bibliography now uses their indexed records as stable locators.

SUPPLEMENTAL LOCATOR VERIFICATION

The additional publisher article locator supplied in reference 20 was successfully opened through the web retrieval service on 21 October 2026. The page returned its bibliographic heading and abstract. This retrieval supplements the 44 attempted locators documented above. The original indexed-abstract link is also retained. No paid PDF access is claimed.